Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS

Continence(2023)10.1016/j.cont.2023.100699Source: DataRank Database

Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS is a research paper published in Continence (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.75)OA: goldTopics (27)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Karl‐Erik Andersson ORCID,Lori A. Birder ORCID,Christopher Fry ORCID,Anthony Kanai ORCID

Live enrichment

PubMed:37389026 OpenAlex:https://openalex.org/W4376881339

U.S. Department of Defense

Grant: P01 DK093424

U.S. Department of Defense

Grant: R01 AG056944

U.S. Department of Defense

Grant: R01 CA251341

U.S. Department of Defense

Grant: R01 DK098361

U.S. Department of Defense

Grant: R01 DK115476

U.S. Department of Defense

Grant: W81XWH1810436

National Institutes of Health

Grant: 5P01DK093424-05

Mechanisms/Treatments of Lower Urinary Tract Dysfunction After Spinal Cord Injury

National Institutes of Health

Grant: 2R01DK098361-06

PDE5 Inhibition of Afferents and Interstitial Cells in Overactive Mouse Bladders

National Institutes of Health

Grant: 1R01AG056944-01A1

Bladder Mucosal Dysfunction During Aging

National Institutes of Health

Grant: 5R01CA251341-03

Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice

National Institutes of Health

Grant: 5R01DK115476-04

Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2023

2024

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.cont.2023.100699

publisherhttps://doi.org/10.1016/j.cont.2023.100699

publisherhttps://api.elsevier.com/content/article/PII:S2772973723001273?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772973723001273?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37389026

Fields of Study

Urinary Bladder and Prostate ResearchMigraine and Headache StudiesSexual function and dysfunction studies03 medical and health sciences0302 clinical medicine

Keywords

TadalafilCyclic guanosine monophosphateMedicinecGMP-specific phosphodiesterase type 5Lower urinary tract symptomsSildenafilInternal medicinePharmacologyEndocrinologyNitric oxideProstatePurine nucleotide phosphorylase (PNPase)570Lower urinary tract symptoms (LUTS)Bladder outlet obstruction (BOO)Benign prostatic hyperplasia (BPH)610Soluble guanylate cyclase (sGC) activatorsRC870-9238-aminoguanine (8AG)Diseases of the genitourinary system. UrologyArticle